Fennec Pharmaceuticals

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$7,925
$6,974
$7,262
$25,377
Gross Profit
7,256
5,617
6,654
24,827
EBITDA
-909
-4,685
-4,483
14,594
EBIT
-934
-4,710
-4,509
13,871
Net Income
-1,619
-5,735
-5,553
12,837
Net Change In Cash
7,925
6,974
7,262
25,377
Free Cash Flow
-1,474
-2,206
-8,040
38,872
Cash
26,634
40,320
43,047
51,131
Basic Shares
27,460
27,371
27,297
31,091

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$47,538
$21,252
$1,535
$170
Gross Profit
44,354
19,993
1,449
0
EBITDA
3,600
-12,364
-22,587
-123
EBIT
2,568
-12,651
-22,736
-17,346
Net Income
-70
-16,045
-24,839
-17,456
Net Change In Cash
47,538
21,252
1,535
170
Cost of Revenue
-9,244
Free Cash Flow
26,980
-17,143
-18,058
-14,222
Cash
26,634
13,269
23,774
21,100
Basic Shares
27,294
26,574
26,275
26,006

Earnings Calls

Quarter EPS
2024-12-31
-$0.06
2024-09-30
-$0.21
2024-06-30
-$0.20
2024-03-31
$0.47